{
  "query": "adverse health least life",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT06779773",
          "briefTitle": "A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Geographic Atrophy", "Macular Degeneration"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02230969",
          "briefTitle": "Plegridy Observational Program"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsing Forms of Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1208,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03387137",
          "briefTitle": "Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2/1030s) in RSV-Seropositive Children and RSV-Seronegative Infants and Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "RSV Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "60 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05831657",
          "briefTitle": "Prevent It 2.0/PRIORITY - An iCBT to Reduce the Risk of Committing Child Sexual Abuse"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pedophilia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 205,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02839681",
          "briefTitle": "Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-07-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06674382",
          "briefTitle": "Haplo-HSCT for Myelofibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myelofibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05255380",
          "briefTitle": "Examine the Effects of Mindfulness in Woman With a History of Child Adversity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Stress", "Psychological Stress", "Child Maltreatment", "Depressive Symptoms", "Signs and Symptoms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "30 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04482062",
          "briefTitle": "TRISCEND II Pivotal Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-06-27",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Tricuspid Valve Regurgitation", "Tricuspid Valve Insufficiency", "Tricuspid Valve Disease", "Heart Valve Diseases", "Cardiovascular Diseases", "Heart Failure"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1070,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03783442",
          "briefTitle": "A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-12-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Esophageal Squamous Cell Carcinoma (ESCC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 649,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02392754",
          "briefTitle": "Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Atrial Fibrillation", "Hypertension"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 856,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01187407",
          "briefTitle": "A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03"
          },
          "completionDateStruct": {
            "date": "2013-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Major Depressive Disorder (MDD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1480,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06472336",
          "briefTitle": "IntraCranial Atherosclerosis Related Large-vessel Occlusion Treated With Urgent Stenting (ICARUS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Stroke", "Stroke, Acute Ischemic", "Intracranial Atherosclerosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 498,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04904198",
          "briefTitle": "A Care Management Intervention for Non-cardiac Chest Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chest Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00664521",
          "briefTitle": "Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-03"
          },
          "completionDateStruct": {
            "date": "2010-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00197145",
          "briefTitle": "Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-07-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-09-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infection, Human Immunodeficiency Virus I"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05438212",
          "briefTitle": "Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03-16",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Malignant Neoplasm in the Brain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 237,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03320330",
          "briefTitle": "Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Malignant Solid Neoplasm", "Recurrent Osteosarcoma", "Refractory Malignant Solid Neoplasm", "Refractory Osteosarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Months",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06491199",
          "briefTitle": "Home Assessment of Blood Pressure in PregnancY"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hypertensive Disorder of Pregnancy"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03350321",
          "briefTitle": "A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Anemia", "Renal Insufficiency, Chronic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 162,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07204834",
          "briefTitle": "A Physical Activity Program for People With Heart Failure"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Heart Failure"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01806298",
          "briefTitle": "An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06"
          },
          "completionDateStruct": {
            "date": "2016-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Adult Growth Hormone Deficiency"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01839487",
          "briefTitle": "PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-09-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Pancreatic Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 279,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02622321",
          "briefTitle": "A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hemophilia A"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 113,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03969212",
          "briefTitle": "Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4138,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04030598",
          "briefTitle": "A Study to Assess the Clinical Efficacy of Donidalorsen (Also Known as IONIS-PKK-LRx and ISIS 721744) in Participants With Hereditary Angioedema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hereditary Angioedema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05878457",
          "briefTitle": "Accelerated rTMS for Post-Stroke Apathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Apathy", "Stroke Sequelae", "Stroke (CVA) or TIA", "Stroke/Brain Attack", "Motivation", "Abulia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05450471",
          "briefTitle": "Effectiveness of Endonasal Polymeric Implant for Chronic Rhinosinusitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Rhinosinusitis Chronic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00961064",
          "briefTitle": "A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myelodysplastic Syndromes", "Thrombocytopenia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04923893",
          "briefTitle": "A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2036-09-22",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 743,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01847521",
          "briefTitle": "Effects of the Anti-inflammatory Flavonoid Luteolin on Behavior in Children With Autism Spectrum Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-12"
          },
          "completionDateStruct": {
            "date": "2013-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Autism Spectrum Disorders"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "10 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07174609",
          "briefTitle": "Scrambler Therapy in Chronic Pancreatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Pain", "Pancreatitis", "Chronic Pancreatitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05678621",
          "briefTitle": "Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Haematological Malignancy", "Hypogammaglobulinemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00420004",
          "briefTitle": "A Study for Participants With Major Depression"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-12"
          },
          "completionDateStruct": {
            "date": "2008-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Major Depressive Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 469,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02626624",
          "briefTitle": "Safety and Efficacy of the CarboClear Pedicle Screw System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Degenerative Disc Disease", "Spondylolisthesis, Grade 1"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 57,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "72 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04241523",
          "briefTitle": "Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatocellular Carcinoma (HCC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00103662",
          "briefTitle": "Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-01"
          },
          "completionDateStruct": {
            "date": "2008-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 302,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "78 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05075161",
          "briefTitle": "Pirfenidone to Prevent Fibrosis in Ards."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Respiratory Distress Syndrome (ARDS)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 130,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01575769",
          "briefTitle": "An Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-12-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Juvenile Idiopathic Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04458051",
          "briefTitle": "Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-14",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Progressive Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 767,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02989857",
          "briefTitle": "Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Cholangiocarcinoma", "Metastatic Cholangiocarcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 187,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00294112",
          "briefTitle": "Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-03-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2006-07-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04843644",
          "briefTitle": "Microbiota and Symptom Distress in Head and Neck Cancer Patients Receiving Radiotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Oral Mucositis", "Microbiota", "Symptoms and Signs"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 250,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01488994",
          "briefTitle": "BAX 326 Pediatric Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-05-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hemophilia B"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04118322",
          "briefTitle": "The Effect of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-09-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-09-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chemotherapy Effect", "Adverse Effect", "Nursing Caries"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03520075",
          "briefTitle": "Study of ASTX029 in Subjects With Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumor, Adult"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 192,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00823719",
          "briefTitle": "Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-05"
          },
          "completionDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Large-Cell, Diffuse"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 61,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00885365",
          "briefTitle": "A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-04"
          },
          "completionDateStruct": {
            "date": "2010-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cystic Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 324,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01797965",
          "briefTitle": "Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-02-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-09-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsing-Remitting Multiple Sclerosis", "Multiple Sclerosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1501,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05168995",
          "briefTitle": "Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 620,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07193277",
          "briefTitle": "Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Focal Epilepsy", "Cognitive Impairment"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 220,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02884453",
          "briefTitle": "Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Gastrooesophageal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01672853",
          "briefTitle": "Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-03-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-08-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Sclerosing Cholangitis (PSC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 235,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05398172",
          "briefTitle": "Clinical Evaluation of Fractional Bi-Polar Radio-Frequency for Symptoms of Vulvovaginal Atrophy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Vaginal Atrophy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "35 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04300556",
          "briefTitle": "A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-08-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 182,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03811002",
          "briefTitle": "Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-02-21",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Limited Stage Lung Small Cell Carcinoma", "Stage I Lung Cancer AJCC v8", "Stage II Lung Cancer AJCC v8", "Stage III Lung Cancer AJCC v8"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 544,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01018953",
          "briefTitle": "Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-02"
          },
          "completionDateStruct": {
            "date": "2011-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoid Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04143594",
          "briefTitle": "Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV-1-infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 183,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05970081",
          "briefTitle": "Effectiveness and Safety of Implantable Intrathecal Systems for Refractory Pain in Spain (INTRATHECAL-RENASED)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Refractory Pain"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 504,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03310957",
          "briefTitle": "Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Triple Negative Breast Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 185,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03977311",
          "briefTitle": "MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-31",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-02-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Locally Advanced Cervical Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06931132",
          "briefTitle": "Cancer-related Fatigue and Symptom Clusters - Effects of Virtual, Imagined and Real-life Nature-based Therapy in Cancer Survivors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cancer Survivors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 172,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02014441",
          "briefTitle": "Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-04-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-04-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 61,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01662102",
          "briefTitle": "Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-12-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-03-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Follicular Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04533737",
          "briefTitle": "Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Plaque Psoriasis", "Psoriasis Vulgaris", "Psoriasis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 113,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02278341",
          "briefTitle": "Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-07-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Anemia", "End Stage Renal Disease (ESRD)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 838,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02502266",
          "briefTitle": "Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-16",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Fallopian Tube Clear Cell Adenocarcinoma", "Fallopian Tube Endometrioid Adenocarcinoma", "Fallopian Tube Serous Adenocarcinoma", "Fallopian Tube Transitional Cell Carcinoma", "Fallopian Tube Undifferentiated Carcinoma", "Ovarian Clear Cell Adenocarcinoma", "Ovarian Endometrioid Adenocarcinoma", "Ovarian Seromucinous Carcinoma", "Ovarian Serous Adenocarcinoma", "Ovarian Transitional Cell Carcinoma", "Ovarian Undifferentiated Carcinoma", "Primary Peritoneal Serous Adenocarcinoma", "Recurrent Fallopian Tube Carcinoma", "Recurrent Ovarian Carcinoma", "Recurrent Primary Peritoneal Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 582,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01438853",
          "briefTitle": "Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-12"
          },
          "completionDateStruct": {
            "date": "2008-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Sepsis", "Acute Lung Injury", "Acute Respiratory Distress Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06265857",
          "briefTitle": "Effect of Multifunctional Nutrition Tube on Cerebral Small Vessel Disease Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cerebral Small Vessel Diseases", "Dysphagia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 88,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06837194",
          "briefTitle": "Washed Microbiota Transplantation Combined with Enteral Nutrition for Gastroptosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Gastroptosis", "Malnutrition"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03903822",
          "briefTitle": "Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 292,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01785537",
          "briefTitle": "The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10"
          },
          "completionDateStruct": {
            "date": "2019-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cardiovascular Diseases", "Chronic Obstructive Pulmonary Diseases", "Cancer of the Lung", "Cancer of the Bladder", "Cancer of the Stomach"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1050,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02256137",
          "briefTitle": "A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Brain Tumor", "Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1564,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04385745",
          "briefTitle": "Treatment of Children's Forearm Shaft Fractures With Biodegradable Intramedullary Nailing, Compared With Elastic Stable Intramedullary Nailing"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Fractures, Bone", "Injury Arm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04444895",
          "briefTitle": "A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Angioedema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 73,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01251367",
          "briefTitle": "Dysport® Adult Lower Limb Spasticity Follow-on Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06"
          },
          "completionDateStruct": {
            "date": "2015-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Post-stroke Spasticity", "Spasticity Post-Traumatic Brain Injury"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 352,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02127762",
          "briefTitle": "The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-09"
          },
          "completionDateStruct": {
            "date": "2016-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus", "Type I Diabetes", "Type II Diabetes", "Diabetic Peripheral Neuropathy", "Chronic Pain"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00112294",
          "briefTitle": "Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-12"
          },
          "completionDateStruct": {
            "date": "2008-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Small-Cell Lung Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 755,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04951622",
          "briefTitle": "A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04-17",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myasthenia Gravis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 219,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01399372",
          "briefTitle": "Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-09"
          },
          "completionDateStruct": {
            "date": "2022-05-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chemotherapeutic Agent Toxicity", "Cognitive/Functional Effects", "Lymphoma", "Neurotoxicity", "Radiation Toxicity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 91,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02676895",
          "briefTitle": "A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-03-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Shigella Sonnei Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 74,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03792256",
          "briefTitle": "Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Lymphocytic", "Lymphoblastic Lymphoma", "T-cell Lymphoma", "T-cell Leukemia", "Recurrent Disease", "Acute Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Months",
          "maximumAge": "31 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07028853",
          "briefTitle": "This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2034-12-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Castration Sensitive Prostate Cancer (mCSPC)", "Hormone Sensitive Prostate Cancer", "Prostate Cancer", "Cancer of the Prostate"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04415853",
          "briefTitle": "Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Esophageal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 416,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01366183",
          "briefTitle": "Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-08-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Stage I Ovarian Cancer AJCC v6 and v7", "Stage IA Fallopian Tube Cancer AJCC v6 and v7", "Stage IB Fallopian Tube Cancer AJCC v6 and v7", "Stage IC Fallopian Tube Cancer AJCC v6 and v7", "Stage II Ovarian Cancer AJCC v6 and v7", "Stage IIA Fallopian Tube Cancer AJCC v6 and v7", "Stage IIB Fallopian Tube Cancer AJCC v6 and v7", "Stage IIC Fallopian Tube Cancer AJCC v6 and v7", "Stage III Ovarian Cancer AJCC v6 and v7", "Stage III Primary Peritoneal Cancer AJCC v7", "Stage IIIA Fallopian Tube Cancer AJCC v7", "Stage IIIB Fallopian Tube Cancer AJCC v7", "Stage IIIC Fallopian Tube Cancer AJCC v7", "Stage IV Fallopian Tube Cancer AJCC v6 and v7", "Stage IV Ovarian Cancer AJCC v6 and v7", "Stage IV Primary Peritoneal Cancer AJCC v7"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 290,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01538251",
          "briefTitle": "Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-04"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 147,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04991337",
          "briefTitle": "Effects of Detraining in Endurance Athletes With Atrial Fibrillation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atrial Fibrillation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05799495",
          "briefTitle": "A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "SARS-CoV-2 Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01655381",
          "briefTitle": "A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-04"
          },
          "completionDateStruct": {
            "date": "2015-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06013865",
          "briefTitle": "Empagliflozin Treatment in Kidney Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Kidney Transplant", "Chronic Kidney Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 264,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02553941",
          "briefTitle": "Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myelomonocytic Leukemia", "de Novo Myelodysplastic Syndrome", "Previously Treated Myelodysplastic Syndrome", "Refractory Anemia With Excess Blasts in Transformation", "Secondary Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03323151",
          "briefTitle": "A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Mantle-Cell Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04567602",
          "briefTitle": "A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Arterial Hypertension"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 372,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00810030",
          "briefTitle": "FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-10"
          },
          "completionDateStruct": {
            "date": "2010-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Inflammatory Bowel Disease", "Anemia", "Iron Deficiency", "Iron-Deficiency Anemia", "Crohn's Disease", "Ulcerative Colitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 484,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00992017",
          "briefTitle": "Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-10"
          },
          "completionDateStruct": {
            "date": "2010-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV Infections", "H1N1 Influenza Virus"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 130,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "39 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03839940",
          "briefTitle": "Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malignant Neoplasm"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07003191",
          "briefTitle": "Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 2600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05815173",
          "briefTitle": "Ladarixin With Sotorasib in Advanced NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05319054",
          "briefTitle": "Pathway of Low Anterior Resection Syndrome Relief After Surgery: a Feasibility Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Low Anterior Resection Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 187,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00952380",
          "briefTitle": "Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Venous Thromboembolism"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05503446",
          "briefTitle": "Using Commonly Available Food Products To Treat Food Allergy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["IgE-Mediated Cow Milk Allergy", "Peanut Allergy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 216,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "23 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT06370260",
          "briefTitle": "Assessing the Efficacy of a Hydrogen Peroxide Gel for Oral Wound Healing and Oral Hygiene"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Wound Heal", "Postoperative Pain", "Biopsy Wound", "Wound; Mouth", "Quality of Life", "Dental Plaque", "Gingival Inflammation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02928224",
          "briefTitle": "Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "BRAF V600E-mutant Metastatic Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 702,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05092646",
          "briefTitle": "Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects With Ankle Osteoarthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ankle Osteoarthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03390842",
          "briefTitle": "Long-term Safety Extension to Study TRCA-301"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metabolic Acidosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 196,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06093191",
          "briefTitle": "Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Bronchiectasis Adult", "Pseudomonas Aeruginosa Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 364,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05198310",
          "briefTitle": "Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 145,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00145470",
          "briefTitle": "12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-06-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-03-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Bipolar Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 326,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05391789",
          "briefTitle": "Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Sepsis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02719574",
          "briefTitle": "Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Myelogenous Leukemia", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 336,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03441360",
          "briefTitle": "Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsed/Refractory Rhabdomyosarcoma", "Non-rhabdomyosarcoma Soft Tissue Sarcoma", "Ewing Sarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Months",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01990859",
          "briefTitle": "Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-12"
          },
          "completionDateStruct": {
            "date": "2015-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02157779",
          "briefTitle": "Treatment of Trauma-Related Anger in OEF/OIF/OND Veterans"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Anger Problems"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07234903",
          "briefTitle": "ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2032-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Spinal Cord Injury", "SCI", "SCI - Spinal Cord Injury", "Subacute Spinal Cord Injury", "Chronic Spinal Cord Injury", "Spinal Cord Injury (SCI)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01881308",
          "briefTitle": "Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 320,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03250676",
          "briefTitle": "Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Neoplasms", "Breast Cancer", "Estrogen-receptor Positive Breast Cancer", "Cancer, Breast", "Breast Cancer Female", "Breast Adenocarcinoma", "Estrogen Receptor Positive Tumor", "ER Positive"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 151,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03612596",
          "briefTitle": "Narrative Visualization for Breast Cancer Survivors' Physical Activity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "55 Years",
          "maximumAge": "79 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04852120",
          "briefTitle": "Compound Sodium Picosulfate Granules for Bowel Preparation in Chinese Population"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Bowel Cleansing"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 3000,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01609296",
          "briefTitle": "IN.PACT Global Clinical Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05"
          },
          "completionDateStruct": {
            "date": "2020-01-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Peripheral Arterial Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1535,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03089879",
          "briefTitle": "A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dysentery, Bacillary"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "22 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00688688",
          "briefTitle": "Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-04-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2010-05-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Urinary Bladder, Overactive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2792,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06402786",
          "briefTitle": "First-in-human Trial of Home Brain Pressure Measured Using Kitea ICP Sensor, Placed During Hydrocephalus Shunt Surgery."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hydrocephalus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05395494",
          "briefTitle": "iTBS-DCS in Fibromyalgia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Fibromyalgia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00528866",
          "briefTitle": "Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05214222",
          "briefTitle": "Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Esophageal Squamous Cell Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03033836",
          "briefTitle": "Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12"
          },
          "completionDateStruct": {
            "date": "2019-06-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03703336",
          "briefTitle": "Phase III Study of Liquid Formulation of ROTAVIN"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diarrhea", "Diarrhea Rotavirus"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 825,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "60 Days",
          "maximumAge": "91 Days"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06905834",
          "briefTitle": "Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Dry Eye Disease (DED)", "Graft-Versus-Host Disease(GVHD)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06908993",
          "briefTitle": "Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-07-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Non Small Cell Lung Cancer", "MET Exon 14 Mutation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 133,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03697993",
          "briefTitle": "Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Urinary Tract Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06073093",
          "briefTitle": "A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-07-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 264,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02510014",
          "briefTitle": "Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Opioid Use Disorder", "Opioid-related Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 775,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03801304",
          "briefTitle": "Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01543204",
          "briefTitle": "Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-05-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Psoriasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 64,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06352749",
          "briefTitle": "Face-to-face vs Online Physical Exercise in Seniors Living in Nursing Homes (ExerMOT-NH)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Physical Function", "Cognitive Decline", "Psychological Well-Being"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00076011",
          "briefTitle": "Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-10"
          },
          "completionDateStruct": {
            "date": "2007-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00568321",
          "briefTitle": "RN624 For Pain Of Post-Herpetic Neuralgia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-12-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2009-01-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neuralgia, Postherpetic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 99,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04011033",
          "briefTitle": "Study of Adoptive Transfer of iNKT Cells Combined With TAE/TACE to Treat Unresectable HCC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatocellular Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05567458",
          "briefTitle": "A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Beta-thalassemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 94,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01732549",
          "briefTitle": "A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01"
          },
          "completionDateStruct": {
            "date": "2015-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Castrate Resistant Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 144,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01847885",
          "briefTitle": "Electrical Stimulation for the Treatment of Chronic Post-Stroke Shoulder Pain Using the Smartpatch System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04"
          },
          "completionDateStruct": {
            "date": "2016-11-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Post-stroke Shoulder Pain", "Hemiplegic Shoulder Pain"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 88,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01727011",
          "briefTitle": "Single Fraction Elderly Breast Irradiation (SiFEBI)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-11"
          },
          "completionDateStruct": {
            "date": "2015-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05047536",
          "briefTitle": "KZR-261 in Subjects With Advanced Solid Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced/Metastatic Solid Tumor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 61,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00472199",
          "briefTitle": "Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-05"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Restless Legs Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 331,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02634281",
          "briefTitle": "Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-06-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Smoking Cessation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 242,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05394519",
          "briefTitle": "A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Overweight", "Obesity", "Type 2 Diabetes Mellitus"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06233799",
          "briefTitle": "Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Methamphetamine-dependence", "Methamphetamine Abuse"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 360,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05204563",
          "briefTitle": "Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 450,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07202052",
          "briefTitle": "Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Myeloma", "Non-Hodgkin's Lymphoma", "Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 900,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04062201",
          "briefTitle": "Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Tuberculosis", "Pre-XDR-TB", "Extensively Drug-Resistant Tuberculosis", "Multi Drug Resistant Tuberculosis", "Rifampicin Resistant Tuberculosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 402,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04253236",
          "briefTitle": "To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA)."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Warm Autoimmune Hemolytic Anemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02725411",
          "briefTitle": "Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Low Back Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 277,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05907057",
          "briefTitle": "An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia (AML)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 245,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01970865",
          "briefTitle": "A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 364,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01526434",
          "briefTitle": "Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01"
          },
          "completionDateStruct": {
            "date": "2014-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04018599",
          "briefTitle": "Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Rheumatoid Arthritis", "Polyarticular Juvenile Idiopathic Arthritis", "Psoriatic Arthritis", "Ankylosing Spondylitis", "Crohn Disease", "Ulcerative Colitis", "Plaque Psoriasis", "Pediatric Plaque Psoriasis", "Pediatric Crohns Disease", "Hidradenitis Suppurativa", "Non-infectious Uveitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 216,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04916587",
          "briefTitle": "Implementation of Adverse Childhood Experiences (ACEs) Policy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Adverse Childhood Experiences"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7645,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "0 Years",
          "maximumAge": "5 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02577406",
          "briefTitle": "An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Myeloid", "Isocitrate Dehydrogenase"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 319,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06733038",
          "briefTitle": "FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 238,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06843811",
          "briefTitle": "Sirolimus for Leigh Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Leigh Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00693992",
          "briefTitle": "Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-05-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Stage IIIB Lung Non-Small Cell Cancer AJCC v7", "Stage IV Non-Small Cell Lung Cancer AJCC v7"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 210,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05496829",
          "briefTitle": "IMPACT Trial: Intervention to iMProve AdherenCe Equitably"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 350,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05001737",
          "briefTitle": "Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Macrophage Activation Syndrome", "Secondary Hemophagocytic Lymphohistiocytosis", "Still Disease", "Systemic Lupus Erythematosus", "SJIA", "AOSD", "MAS"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03381196",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza A"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 553,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "13 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04093362",
          "briefTitle": "Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Cholangiocarcinoma", "FGFR2 Gene Rearrangements"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06741761",
          "briefTitle": "12-hour Time Limited Feeding in Critical Care"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Critical Illness"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01251588",
          "briefTitle": "Extension Study for Participants of MACI00206 Study of MACI® for the Treatment of Symptomatic Articular Cartilage Defects of the Knee"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12"
          },
          "completionDateStruct": {
            "date": "2015-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Articular Cartilage Defects"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 128,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00388973",
          "briefTitle": "Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-09"
          },
          "completionDateStruct": {
            "date": "2007-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Major Depressive Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 338,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "66 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01266031",
          "briefTitle": "Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-07-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Malignant Glioma", "Recurrent Glioblastoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 96,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06589986",
          "briefTitle": "A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Moderately to Severely Active Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 400,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00810069",
          "briefTitle": "Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-11"
          },
          "completionDateStruct": {
            "date": "2010-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Major Depressive Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 840,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07173166",
          "briefTitle": "Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03245151",
          "briefTitle": "Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-11-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Recurrent and Refractory Solid Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 64,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04757337",
          "briefTitle": "Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Soft-tissue Sarcoma", "Metastatic Soft-tissue Sarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 214,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02796872",
          "briefTitle": "The Effect of Feeding Infant Formula With Bimuno Galactooligosaccharide (GOS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dietary Modification"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 392,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "12 Days",
          "maximumAge": "18 Days"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01926886",
          "briefTitle": "A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-07-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 102,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05760794",
          "briefTitle": "Barbed-suture Efficiency Study for Sacrocolpopexy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Prolapse; Female"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "21 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03677856",
          "briefTitle": "The Effectiveness of ThOracic Epidural and Paravertebral Blockade In Reducing Chronic Post- Thoracotomy Pain: 2"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Anesthesia", "Thoracic Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1026,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04681729",
          "briefTitle": "Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cold Urticaria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03085095",
          "briefTitle": "A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1134,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05521412",
          "briefTitle": "EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer", "Metastatic Castration-resistant Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02574286",
          "briefTitle": "Study of the Effect of Velaglucerase Alfa (VPRIV®) on Bone-related Pathology in Treatment-naïve Participants With Type 1 Gaucher Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Gaucher Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06016842",
          "briefTitle": "A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Biliary Cholangitis (PBC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 276,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00331773",
          "briefTitle": "Radiation Therapy in Treating Patients With Stage II Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1116,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02879305",
          "briefTitle": "Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-11-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Anaemia", "Aspergillosis, Allergic Bronchopulmonary"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2964,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02931539",
          "briefTitle": "Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cytomegalovirus (CMV)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 352,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03552757",
          "briefTitle": "Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Obesity", "Overweight"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1210,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04631562",
          "briefTitle": "Study of ALXN1820 in Healthy Adult Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03635788",
          "briefTitle": "The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 456,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03232073",
          "briefTitle": "Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 877,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02960854",
          "briefTitle": "A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-01-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Sepsis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03918629",
          "briefTitle": "Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Clostridium Difficile Associated Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1994,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05799131",
          "briefTitle": "Safety and Efficacy of the QBX Peripheral Balloon Expandable Stent System in Peripheral Artery Disease (PAD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Peripheral Arterial Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06040762",
          "briefTitle": "A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Bladder Cancer", "Urothelial Carcinoma", "Upper Tract Urothelial Carcinoma", "Renal Pelvis and Ureter Urothelial Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 128,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04801446",
          "briefTitle": "Transcranial Direct Current Stimulation in Acute Ischemic Stroke Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Stroke"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01122927",
          "briefTitle": "Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-07"
          },
          "completionDateStruct": {
            "date": "2014-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adolescent Schizophrenia", "Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 524,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "10 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03547986",
          "briefTitle": "BIO REsponse Adapted Combination Therapy Pilot Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Peripheral Arterial Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07139470",
          "briefTitle": "Sacituzumab Tirumotecan Plus Anlotinib for Metastatic Triple Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-10-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Triple Negative Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 59,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01300988",
          "briefTitle": "Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12"
          },
          "completionDateStruct": {
            "date": "2013-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02624986",
          "briefTitle": "A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Hodgkin's Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06003283",
          "briefTitle": "Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 134,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      }
    ],
    "protocolSection.2": [
      {
        "identificationModule": {
          "nctId": "NCT05678959",
          "briefTitle": "Long-term Extension Study of Ligelizumab in Food Allergy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Food Allergy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 163,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "57 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01135459",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-06-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 183,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00001379",
          "briefTitle": "Treatment and Natural History Study of Lymphomatoid Granulomatosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1995-05-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphomatoid Granulomatosis", "Granulomatosis, Lymphomatoid", "Non-Hodgkins Lymphoma", "Lymphoproliferative Disorder"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 94,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06170827",
          "briefTitle": "Study to Evaluate the AIO-001 in Healthy Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Respiratory Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05411874",
          "briefTitle": "A Multicenter Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITP"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-10-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Thrombocytopenia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04221490",
          "briefTitle": "2019-06 TRISCEND Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Tricuspid Valve Regurgitation", "Heart Valve Diseases", "Cardiovascular Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 228,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05867160",
          "briefTitle": "Adjunctive Anti-seizure Medication (ASM) Real World Evidence (RWE) Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Epilepsy"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02317627",
          "briefTitle": "Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12"
          },
          "completionDateStruct": {
            "date": "2016-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Psoriasis Vulgaris"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06486883",
          "briefTitle": "Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Breast Cancer", "Advanced Breast Carcinoma", "Hormone Receptor Positive Breast Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05586100",
          "briefTitle": "Neoadjuvant and Adjuvant Toripalimab and Cetuximab in Patients With Recurrent, Resectable Squamous Cell Carcinoma of Head and Neck: a Prospective, Single-arm,Phase II Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03312907",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 292,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06007144",
          "briefTitle": "Performance of the SPIRION Laryngeal Pacemaker in BVFP Patients With Single-sided Glottal Enlargement"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Bilateral Vocal Cord Paralysis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05000216",
          "briefTitle": "COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Rheumatoid Arthritis (RA)", "Systemic Lupus Erythematosus (SLE)", "Pemphigus Vulgaris", "Multiple Sclerosis (MS)", "Systemic Sclerosis (SSc)", "Pediatric SLE", "Juvenile Idiopathic Arthritis (JIA)", "Juvenile Dermatomyositis (JDM)", "Pediatric-Onset Multiple Sclerosis (POMS)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 258,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01538706",
          "briefTitle": "Hospital-based Home Care for Children With Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-08"
          },
          "completionDateStruct": {
            "date": "2010-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Neoplasms", "Children"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Month",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01631552",
          "briefTitle": "Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Gastric Adenocarcinoma", "Esophageal Cancer", "Hepatocellular Carcinoma", "Non-small Cell Lung Cancer", "Small Cell Lung Cancer", "Ovarian Epithelial Cancer", "Carcinoma Breast Stage IV", "Hormone-refractory Prostate Cancer", "Head and Neck Cancers- Squamous Cell", "Renal Cell Cancer", "Urinary Bladder Neoplasms", "Cervical Cancer", "Endometrial Cancer", "Glioblastoma Multiforme", "Triple Negative Breast Cancer", "Pancreatic Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 515,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00265148",
          "briefTitle": "Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-05-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2008-07-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alzheimer's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04485611",
          "briefTitle": "Prehabilitation of Veterans With Exercise and Nutrition"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Frailty"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01981187",
          "briefTitle": "LGX818 for Patients With BRAFV600 Mutated Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-10-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Solid Tumor", "Hematologic Malignancies"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04736706",
          "briefTitle": "A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Renal Cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1653,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05921552",
          "briefTitle": "Senior Adult Hepatobiliary Prehab Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-11-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatobiliary Cancer", "Cholangiocarcinoma", "Liver Metastases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05201547",
          "briefTitle": "Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Endometrial Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 260,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04378049",
          "briefTitle": "Robot-Assisted Partial Knee Replacement Versus Standard Total Knee Replacement"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Knee Osteoarthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 64,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04585893",
          "briefTitle": "Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multicentric Castleman Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01777893",
          "briefTitle": "Effect of Diet and Physical Activity on Incidence of Type 2 Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06"
          },
          "completionDateStruct": {
            "date": "2018-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pre-diabetes", "Obesity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "10 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02370238",
          "briefTitle": "A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 194,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03611985",
          "briefTitle": "Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05530187",
          "briefTitle": "ePRO-based Model of Care to Manage and Monitoring Symptoms of Cancer Patients Treated With Immune Checkpoint Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Patient Reported Outcome Measures", "Patient Safety"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 198,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02227238",
          "briefTitle": "Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 627,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03136926",
          "briefTitle": "Screening Anti-Fungal Exposure in Intensive Care Units"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Antifungal Agents"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03834155",
          "briefTitle": "Enhancing Cardiac Rehabilitation Through Behavioral Nudges"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myocardial Infarction", "Percutaneous Coronary Intervention", "Coronary Artery Disease", "Valvular Disease", "Chronic Stable Angina", "Chronic Stable Heart Failure"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 447,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07237399",
          "briefTitle": "Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-02",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2031-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Oligometastatic Prostate Cancer (OMPC)", "Prostate Cancer (Adenocarcinoma)", "Ablation Techniques"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02499055",
          "briefTitle": "A Randomised Feasibility Trial With Internet Based Self-help Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-08"
          },
          "completionDateStruct": {
            "date": "2017-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Anxiety"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 64,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04399538",
          "briefTitle": "Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-04-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Nonalcoholic Steatohepatitis", "Nonalcoholic Fatty Liver Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05314998",
          "briefTitle": "Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2031-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pancreatic Ductal Adenocarcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 394,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "79 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05763563",
          "briefTitle": "Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma", "Leukemia", "Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05349721",
          "briefTitle": "Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Amyotrophic Lateral Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 336,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07110714",
          "briefTitle": "Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Post COVID-19 Condition", "Post COVID-19 Condition (PCC)", "Post COVID-19", "Post COVID-19 Syndrome", "Long COVID-19 Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00790933",
          "briefTitle": "An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-05-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ulcerative Colitis", "Crohn's Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2243,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05959447",
          "briefTitle": "Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-07-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cough", "Healthy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02455362",
          "briefTitle": "Opioids for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-05"
          },
          "completionDateStruct": {
            "date": "2018-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Obstructive Pulmonary Disease", "Dyspnea"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01853618",
          "briefTitle": "Tremelimumab With Chemoembolization or Ablation for Liver Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-06-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Heptocellular Cancer", "Biliary Tract Neoplasms", "Liver Cancer", "Hepatocellular Carcinoma", "Biliary Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 61,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06319196",
          "briefTitle": "Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02-27",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-02-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cutaneous Melanoma", "Melanoma Stage IV", "Mucosal Melanoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06976710",
          "briefTitle": "PRIORITY-CONNECT 2 Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-07-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Colorectal Cancer", "Colorectal Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 564,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01262560",
          "briefTitle": "Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02"
          },
          "completionDateStruct": {
            "date": "2014-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Dysphagia", "Lung Cancer", "Pain", "Esophagitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 163,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03568188",
          "briefTitle": "Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 170,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "50 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06272162",
          "briefTitle": "Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Locally Advanced Pancreatic Adenocarcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07170982",
          "briefTitle": "Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-10-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Endometrial Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 128,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01859091",
          "briefTitle": "Pilot Study on the Submental Area"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10"
          },
          "completionDateStruct": {
            "date": "2014-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Body Fat Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02763579",
          "briefTitle": "A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Small Cell Lung Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 503,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00910091",
          "briefTitle": "The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-08"
          },
          "completionDateStruct": {
            "date": "2013-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Endometrial Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 73,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04868591",
          "briefTitle": "Single Session Compared to Multiple Sessions of Education and Exercise for Older Adults With Spinal Pain in an Advanced Practice Physiotherapy Model of Care"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Musculoskeletal Pain Disorder", "Spinal Pain"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 109,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02181413",
          "briefTitle": "A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Multiple Myeloma", "Autologous Stem Cell Transplant"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 656,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00603525",
          "briefTitle": "Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-01"
          },
          "completionDateStruct": {
            "date": "2013-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 169,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06333210",
          "briefTitle": "Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Axial Spondyloarthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 421,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01599624",
          "briefTitle": "Stress Resilience Training System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-10"
          },
          "completionDateStruct": {
            "date": "2015-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Stress", "Anxiety", "Depression", "PTSD"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 68,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03233724",
          "briefTitle": "Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Carcinoma, Non-Small-Cell Lung", "Lung Cancer", "Non-Small Cell Lung Cancer", "Carcinoma, Esophageal", "Malignant Pleural Mesotheliomas"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05550623",
          "briefTitle": "Pneumatic Tourniquet Versus no Tourniquet in Transfemoral Amputation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Amputation", "Blood Loss"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 124,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04687579",
          "briefTitle": "Elective Umbilical Hernia Repair in Patients With Cirrhosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cirrhosis, Umbilical Hernia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07313176",
          "briefTitle": "Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Parkinson Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 215,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00969059",
          "briefTitle": "Study in Neuropathic Pain Patients With Peripheral Nerve Injury"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-08"
          },
          "completionDateStruct": {
            "date": "2010-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pain, Neuropathic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 168,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02669017",
          "briefTitle": "Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03"
          },
          "completionDateStruct": {
            "date": "2019-02-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Non-Hodgkin Lymphoma", "Burkitt's Lymphoma", "Chronic Lymphocytic Leukemia", "Lymphoma, Large B-Cell, Diffuse", "Lymphoma, Follicular", "Lymphoma, Mantle-Cell", "Lymphoma, Marginal Zone", "Waldenstrom Macroglobulinemia", "Primary Mediastinal B-cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 183,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03703440",
          "briefTitle": "Group Education Trial to Improve Transition in Type 1 Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus, Type 1", "Type1diabetes", "Insulin Dependent Diabetes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 212,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00123474",
          "briefTitle": "Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-07"
          },
          "completionDateStruct": {
            "date": "2014-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myeloid Leukemia, Chronic, Chronic-Phase"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 724,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05038410",
          "briefTitle": "Study to Investigate the Mechanism of Action of an Oral Enzyme Treatment With Bromelain, Trypsin and Rutoside Versus Placebo in Subjects With OsTeoarthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Osteoarthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00864097",
          "briefTitle": "Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-08-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2010-11-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Osteoarthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 607,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04745520",
          "briefTitle": "Randomized Clinical Trial of Rib Fixation Versus Medical Analgesia in Uncomplicated Rib Fractures on Pain Control."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rib Fractures"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 102,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03948789",
          "briefTitle": "Phase III Study of MR-Guided Focused Ultrasound Surgery for the Treatment of Uterine Fibroids Compared to Myomectomy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Uterine Fibroids"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 127,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06536023",
          "briefTitle": "This is a Study to Evaluate the Pharmacokinetics and Safety of IBI362 in Chinese Adolescents With Obesity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Adolescents With Obesity"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06873035",
          "briefTitle": "An Interventional Study of Infigratinib in Children With Hypochondroplasia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hypochondroplasia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05147740",
          "briefTitle": "Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "HIV-1-infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07221825",
          "briefTitle": "Low-Count Quantitative SPECT for Men Treated With Radium-223"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer", "Cancer of the Prostate"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06408935",
          "briefTitle": "Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-03-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04589650",
          "briefTitle": "Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-01-17",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "PIK3CA-related Overgrowth Spectrum (PROS)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 203,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "0 Days",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04494425",
          "briefTitle": "Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced or Metastatic Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 866,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "105 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06719089",
          "briefTitle": "Evaluation of the Safety and Performance of the Hydrustent® Biodegradable Hydrogel Ureteral Stent"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Urinary Lithiasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 134,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07124390",
          "briefTitle": "Electroacupuncture as a Treatment for Refractory Overactive Bladder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-06-20",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Over Active Bladder", "Urinary Incontinence (UI)", "Nocturia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03587116",
          "briefTitle": "A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hemophilia B", "Hemophilia A"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 212,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00096447",
          "briefTitle": "Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-11"
          },
          "completionDateStruct": {
            "date": "2011-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Recurrent Endometrial Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03725852",
          "briefTitle": "A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Pulmonary Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 68,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02681848",
          "briefTitle": "What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Smoking Cessation", "Cardiovascular Disease", "Respiratory Disease", "Myocardial Infarction", "Depression", "Anxiety"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 180000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05269355",
          "briefTitle": "A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leiomyosarcoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 359,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02305849",
          "briefTitle": "A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-11-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 519,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05474755",
          "briefTitle": "To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 591,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03907748",
          "briefTitle": "Home-based Family Caregiver-delivered Music and Reading Interventions for People With Dementia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Dementia", "Dementia, Vascular", "Dementia With Lewy Bodies", "Dementia, Mixed", "Dementia Alzheimers", "Behavioural and Psychiatric Symptoms of Dementia", "Depression", "Quality of Life"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 864,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05380531",
          "briefTitle": "Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cesarean Section Complications", "Opioid Use"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04512339",
          "briefTitle": "Dupilumab in Severe Chronic Hand Eczema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hand Eczema"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01705977",
          "briefTitle": "Belimumab Assessment of Safety in SLE"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-11-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4019,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05140278",
          "briefTitle": "Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable Artesunate"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Malaria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Months",
          "maximumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05001815",
          "briefTitle": "CSII Versus MDI in Pregnant Women With Type 2 Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Type 2 Diabetes", "Pregnancy in Diabetic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02864992",
          "briefTitle": "Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification", "Lung Adenocarcinoma Stage IIIB/IV"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 337,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03219333",
          "briefTitle": "A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Carcinoma, Transitional Cell", "Urinary Bladder Neoplasms", "Urologic Neoplasms", "Renal Pelvis Neoplasms", "Urothelial Cancer", "Ureteral Neoplasms", "Urethral Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 219,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06243952",
          "briefTitle": "Brain Controlled Spinal Cord Stimulation In Participants With Spinal Cord Injury For Lower Limb Rehabilitation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Spinal Cord Injuries", "Paraplegia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02880371",
          "briefTitle": "A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Solid Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06788587",
          "briefTitle": "Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Methamphetamine Abuse", "Methamphetamine-dependence", "Addiction", "Substance Abuse", "Methamphetamine Use Disorder"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03631706",
          "briefTitle": "M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 304,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04518306",
          "briefTitle": "Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hypertension"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 755,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04318548",
          "briefTitle": "Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infections, Meningococcal"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 945,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03197025",
          "briefTitle": "Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Human Papillomavirus", "HPV-16", "High Grade Squamous Intraepithelial Lesion"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04476576",
          "briefTitle": "Aerobic Exercise is Cardio-protective in Hemato-oncological Disease and New-onset Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cardiotoxicity", "Systolic Dysfunction", "Exercise, Aerobic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04143217",
          "briefTitle": "Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Attention-Deficit/Hyperactivity Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 159,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      }
    ]
  }
}
